11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation
The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
Abstract
CONTEXT: 11Beta-hydroxysteroid dehydrogenase (11beta-HSD) enzymes are now appreciated to be important regulators of hormone action at a tissue level. 11Beta-HSD1 is widely expressed and increases glucocorticoid action through its unique ability to convert inactive glucocorticoids (cortisone in man, 11-dehydrocorticosterone in rodents) to their active forms (cortisol and corticosterone, respectively). The enzyme has roles in the normal hypothalamus-pituitary-adrenal (HPA) axis, has been implicated in metabolic syndrome, and may modulate various aspects of the immune response. EVIDENCE ACQUISITION: A review of published, peer-reviewed medical literature (1990 to June 2009) on the physiology and pathophysiology of 11beta-HSD1 was performed with an emphasis on HPA axis consequences, the metabolic syndrome, and the inflammatory response. EVIDENCE SYNTHESIS: Studies of patients with genetic defects in 11beta-HSD1 action show abnormal HPA axis responses with hyperandrogenism being a major consequence. The mechanisms underlying these abnormalities have been explored in mouse models with targeted deletion of components of the 11beta-HSD1 system. A range of experimental studies emphasize the role of 11beta-HSD1 in the metabolic syndrome and the potential for treatment with chemical inhibitors. An emerging area is the role of 11beta-HSD1 in the inflammatory response. CONCLUSIONS: 11Beta-HSD1 activity is an important component of the HPA axis and contributes to the metabolic syndrome and the normal immune response. Ongoing clinical observations and the development of selective inhibitors will further clarify the role of 11beta-HSD1 in these areas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“thereby regenerating active glucocorticoids within tissues by exploiting the circulating high levels of inert cortisone11.”
From Corticosteroids (2016) · cites this paper as [11]
In the citing paper
“However, 11β-HSD1 acts as a predominant 11β-reductase in all the glucocorticoid target tissues such as the liver, adipose tissue, brain and lung, and facilitates the conversion of inactive precursor cortisone to bioactive cortisol”
From Corticosteroids (2016) · cites this paper as [11]
In the citing paper
“inhibitors of 11β-HSD1 have been designed to limit the adverse metabolic side effects of increased endogenous glucocorticoids in conditions such as Cushing's syndrome.”
From Corticosteroids (2016) · cites this paper as [11]
In the citing paper
“In fact, impaired hepatic 11b-HSD1 occurs in patients with polycystic ovary syndrome and primary obesity11.”
From Corticosteroids (2016) · cites this paper as [11]
In the citing paper
“Thus, the contrasting functions of the isoenzymes 11β-HSD1 and 11β-HSD2 maintain glucocorticoid availability and activity at the cellular level”
From Corticosteroids (2016) · cites this paper as [11]
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Self-citation11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citationKotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationDoes central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Self-citationGlucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 613
Landewé, R. B. M., Boers, M., Verhoeven, A. C., Westhovens, R., van de Laar, M. A. F. J., Markusse, H. M., van Denderen, J. C., Westedt, M. L., Peeters, A. J., Dijkmans, B. A. C., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10083 · Cited by 612
The glucose-6-phosphatase system
SCHAFTINGEN, E. V., & Gerin, I. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620513 · Cited by 495
Morton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 439
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
Self-citationStewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398
Self-citationRask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386
Bone loss in inflammatory disorders
Hardy, R., & Cooper, M. S. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0568 · Cited by 365
Self-citationHermanowski-Vosatka, A., Balkovec, J. M., Cheng, K., Chen, H. Y., Hernandez, M., Koo, G. C., Le Grand, C. B., Li, Z., Metzger, J. M., Mundt, S. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050119 · Cited by 364
Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
Self-citationWalker, B. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3155 · Cited by 277
Alberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263
Adipocyte-Specific Glucocorticoid Inactivation Protects Against Diet-Induced Obesity
Kershaw, E. E., Morton, N. M., Dhillon, H., Ramage, L., Seckl, J. R., & Flier, J. S. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1023 · Cited by 253
Sandeep, T. C., Yau, J. L. W., MacLullich, A. M. J., Noble, J., Deary, I. J., Walker, B. R., & Seckl, J. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306996101 · Cited by 247
Wake, D. J., Rask, E., Livingstone, D. E. W., Söderberg, S., Olsson, T., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030286 · Cited by 231
Cooper, M. S., Bujalska, I., Rabbitt, E., Walker, E. A., Bland, R., Sheppard, M. C., Hewison, M., & Stewart, P. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1037 · Cited by 227
Self-citationLindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030017 · Cited by 225
Tomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., & Stewart, P. M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8168 · Cited by 222
Self-citationHarris, H. J., Kotelevtsev, Y., Mullins, J. J., Seckl, J. R., & Holmes, M. C. (2001) · Endocrinology · doi:10.1210/endo.142.1.7887 · Cited by 209
Lavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512635200 · Cited by 207
Self-citationKannisto, K., Pietiläinen, K. H., Ehrenborg, E., Rissanen, A., Kaprio, J., Hamsten, A., & Yki-Järvinen, H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0153 · Cited by 205
Sandeep, T. C., Andrew, R., Homer, N. Z. M., Andrews, R. C., Smith, K., & Walker, B. R. (2005) · Diabetes · doi:10.2337/diabetes.54.3.872 · Cited by 205
Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
Self-citationExcitation-contraction coupling in vertebrate skeletal muscle: A tale of two calcium channels
Catterall, W. A. (1991) · Cell · doi:10.1016/0092-8674(91)90309-m · Cited by 197
Tomlinson, J. W., Sinha, B., Bujalska, I., Hewison, M., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020687 · Cited by 187
Self-citationTumor Necrosis Factor α and Interleukin 1β Enhance the Cortisone/Cortisol Shuttle
Escher, G., Galli, I., Vishwanath, B. S., Frey, B. M., & Frey, F. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.189 · Cited by 179
Westerbacka, J., Yki-Järvinen, H., Vehkavaara, S., Häkkinen, A.-M., Andrew, R., Wake, D. J., Seckl, J. R., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030596 · Cited by 178
Thieringer, R., Le Grand, C. B., Carbin, L., Cai, T.-Q., Wong, B., Wright, S. D., & Hermanowski-Vosatka, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.30 · Cited by 175
Valsamakis, G., Anwar, A., Tomlinson, J. W., Shackleton, C. H. L., McTernan, P. G., Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032240 · Cited by 160
Self-citationOlsen, N. J., Sokka, T., Seehorn, C. L., Kraft, B., Maas, K., Moore, J. H., & Aune, T. M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017194 · Cited by 153
Hewitt, K. N., Walker, E. A., & Stewart, P. M. (2005) · Endocrinology · doi:10.1210/en.2005-0117 · Cited by 149
Self-citationGilmour, J. S., Coutinho, A. E., Cailhier, J.-F., Man, T. Y., Clay, M., Thomas, G., Harris, H. J., Mullins, J. J., Seckl, J. R., Savill, J. S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7605 · Cited by 143
Molecular Basis of Human Salt Sensitivity: The Role of the 11β-Hydroxysteroid Dehydrogenase Type 2*
Lovati, E., Ferrari, P., Dick, B., Jostarndt, K., Frey, B. M., Frey, F. J., Schorr, U., & Sharma, A. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6098 · Cited by 142
WALKER, B. R., YAU, J. L., BRETT, L. P., SECKL, J. R., MONDER, C., WILLIAMS, B. C., & EDWARDS, C. R. W. (1991) · Endocrinology · doi:10.1210/endo-129-6-3305 · Cited by 142
11&Bgr;-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Morton, N. M., & Seckl, J. R. (2008) · Frontiers of Hormone Research · doi:10.1159/000115363 · Cited by 134
Tomlinson, J. W., Finney, J., Gay, C., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0495 · Cited by 131
Self-citationRapid Hepatic Metabolism of 7-Ketocholesterol by 11β-Hydroxysteroid Dehydrogenase Type 1
Schweizer, R. A. S., Zürcher, M., Balazs, Z., Dick, B., & Odermatt, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313615200 · Cited by 130
Cortisol Release From Adipose Tissue by 11β-Hydroxysteroid Dehydrogenase Type 1 in Humans
Stimson, R. H., Andersson, J., Andrew, R., Redhead, D. N., Karpe, F., Hayes, P. C., Olsson, T., & Walker, B. R. (2009) · Diabetes · doi:10.2337/db08-0969 · Cited by 128
Rask, E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3330 · Cited by 126
Local and systemic glucocorticoid metabolism in inflammatory arthritis
Hardy, R., Rabbitt, E. H., Filer, A., Emery, P., Hewison, M., Stewart, P. M., Gittoes, N. J., Buckley, C. D., Raza, K., & Cooper, M. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090662 · Cited by 118
Self-citationDavani, B., Khan, A., Hult, M., Mårtensson, E., Okret, S., Efendic, S., Jörnvall, H., & Oppermann, U. C. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000600200 · Cited by 114
Morton, N. M., Ramage, L., & Seckl, J. R. (2004) · Endocrinology · doi:10.1210/en.2003-1674 · Cited by 111
Whorwood, C. B., Donovan, S. J., Wood, P. J., & Phillips, D. I. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7503 · Cited by 102
Omental 11β‐hydroxysteroid Dehydrogenase 1 Correlates with Fat Cell Size Independently of Obesity
Michailidou, Z., Jensen, M. D., Dumesic, D. A., Chapman, K. E., Seckl, J. R., Walker, B. R., & Morton, N. M. (2007) · Obesity · doi:10.1038/oby.2007.618 · Cited by 102
Haas, C. S., Creighton, C. J., Pi, X., Maine, I., Koch, A. E., Haines, G. K., Ling, S., Chinnaiyan, A. M., & Holoshitz, J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21953 · Cited by 102
Jamieson, A., Wallace, A. M., Andrew, R., Nunez, B. S., Walker, B. R., Fraser, R., White, P. C., & Connell, J. M. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6031 · Cited by 100
Lavery, G. G., Walker, E. A., Turan, N., Rogoff, D., Ryder, J. W., Shelton, J. M., Richardson, J. A., Falciani, F., White, P. C., Stewart, P. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710067200 · Cited by 99
Self-citationHardy, R. S., Filer, A., Cooper, M. S., Parsonage, G., Raza, K., Hardie, D. L., Rabbitt, E. H., Stewart, P. M., Buckley, C. D., & Hewison, M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1993 · Cited by 98
Self-citationCai, T.-Q., Wong, B., Mundt, S. S., Thieringer, R., Wright, S. D., & Hermanowski-Vosatka, A. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00041-3 · Cited by 98
Zhang, T. Y., Ding, X., & Daynes, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.879 · Cited by 97
The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response
Chapman, K. E., Coutinho, A. E., Gray, M., Gilmour, J. S., Savill, J., & Seckl, J. R. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.031 · Cited by 96
Lavery, G. G., Walker, E. A., Tiganescu, A., Ride, J. P., Shackleton, C. H. L., Tomlinson, J. W., Connell, J. M. C., Ray, D. W., Biason-Lauber, A., Malunowicz, E. M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0743 · Cited by 95
Self-citationWeight Loss Increases 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
Tomlinson, J. W., Moore, J. S., Clark, P. M. S., Holder, G., Shakespeare, L., & Stewart, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031376 · Cited by 90
Self-citationHult, G. T. M., Elleby, B., Shafqat, N., Svensson, S., Rane, A., J�rnvall, H., Abrahmsén, L., & Oppermann, U. C. T. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3476-y · Cited by 86
Christy, C., Hadoke, P. W. F., Paterson, J. M., Mullins, J. J., Seckl, J. R., & Walker, B. R. (2003) · Hypertension · doi:10.1161/01.hyp.0000088855.06598.5b · Cited by 86
A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
Bujalska, I. J., Gathercole, L. L., Tomlinson, J. W., Darimont, C., Ermolieff, J., Fanjul, A. N., Rejto, P. A., & Stewart, P. M. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0050 · Cited by 84
Self-citationStimson, R. H., Johnstone, A. M., Homer, N. Z. M., Wake, D. J., Morton, N. M., Andrew, R., Lobley, G. E., & Walker, B. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0692 · Cited by 83
Apparent cortisone reductase deficiency: a unique form of hypercortisolism
Phillipov, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3855 · Cited by 83
Shimojo, M., Ricketts, M. L., Petrelli, M. D., Moradi, P., Johnson, G. D., Bradwell, A. R., Hewison, M., Howie, A. J., & Stewart, P. M. (1997) · Endocrinology · doi:10.1210/endo.138.3.4994 · Cited by 80
Self-citationVeilleux, A., Rhéaume, C., Daris, M., Luu-The, V., & Tchernof, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2011 · Cited by 78
Drake, A. J., Livingstone, D. E. W., Andrew, R., Seckl, J. R., Morton, N. M., & Walker, B. R. (2005) · Endocrinology · doi:10.1210/en.2004-1063 · Cited by 77
11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents
Boyle, C. D., & Kowalski, T. J. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902967658 · Cited by 74
Dzyakanchuk, A. A., Balázs, Z., Nashev, L. G., Amrein, K. E., & Odermatt, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.009 · Cited by 73
Depot‐specific Regulation of the Conversion of Cortisone to Cortisol in Human Adipose Tissue
Lee, M., Fried, S. K., Mundt, S. S., Wang, Y., Sullivan, S., Stefanni, A., Daugherty, B. L., & Hermanowski‐Vosatka, A. (2008) · Obesity · doi:10.1038/oby.2008.207 · Cited by 73
Freeman, L., Hewison, M., Hughes, S. V., Evans, K. N., Hardie, D., Means, T. K., & Chakraverty, R. (2005) · Blood · doi:10.1182/blood-2005-01-0186 · Cited by 71
Schmidt, M., Weidler, C., Naumann, H., Anders, S., Schölmerich, J., & Straub, R. H. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21091 · Cited by 70
Swali, A., Walker, E. A., Lavery, G. G., Tomlinson, J., & Stewart, P. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1137-2 · Cited by 69
Self-citationCarter, R. N., Paterson, J. M., Tworowska, U., Stenvers, D. J., Mullins, J. J., Seckl, J. R., & Holmes, M. C. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01899.x · Cited by 68
A Switch in the Mechanism of Hypertension in the Syndrome of Apparent Mineralocorticoid Excess
Bailey, M. A., Paterson, J. M., Hadoke, P. W. F., Wrobel, N., Bellamy, C. O. C., Brownstein, D. G., Seckl, J. R., & Mullins, J. J. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040401 · Cited by 66
Morton, N. M., Densmore, V., Wamil, M., Ramage, L., Nichol, K., Bünger, L., Seckl, J. R., & Kenyon, C. J. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3371 · Cited by 66
Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans
Basu, R., Basu, A., Grudzien, M., Jung, P., Jacobson, P., Johnson, M., Singh, R., Sarr, M., & Rizza, R. A. (2009) · Diabetes · doi:10.2337/db08-1079 · Cited by 64
Walker, E. A., Ahmed, A., Lavery, G. G., Tomlinson, J. W., Kim, S. Y., Cooper, M. S., Ride, J. P., Hughes, B. A., Shackleton, C. H. L., McKiernan, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704144200 · Cited by 59
Self-citationHenschkowski, J., Stuck, A. E., Frey, B. M., Gillmann, G., Dick, B., Frey, F. J., & Mohaupt, M. G. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.152 · Cited by 58
Atanasov, A. G., Nashev, L. G., Gelman, L., Legeza, B., Sack, R., Portmann, R., & Odermatt, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.03.001 · Cited by 58
Molecular Basis of Human Salt Sensitivity: The Role of the 11 -Hydroxysteroid Dehydrogenase Type 2
Lovati, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3745 · Cited by 56
Rogoff, D., Ryder, J. W., Black, K., Yan, Z., Burgess, S. C., McMillan, D. R., & White, P. C. (2007) · Endocrinology · doi:10.1210/en.2007-0593 · Cited by 55
Discovery and biological evaluation of adamantyl amide 11β-HSD1 inhibitors
Webster, S. P., Ward, P., Binnie, M., Craigie, E., McConnell, K. M. M., Sooy, K., Vinter, A., Seckl, J. R., & Walker, B. R. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.057 · Cited by 53
Yong, P. Y. K. (2002) · Human Reproduction · doi:10.1093/humrep/17.9.2300 · Cited by 53
Ishii, T., Masuzaki, H., Tanaka, T., Arai, N., Yasue, S., Kobayashi, N., Tomita, T., Noguchi, M., Fujikura, J., Ebihara, K., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2006.11.032 · Cited by 51
Tu, H., Powers, J. P., Liu, J., Ursu, S., Sudom, A. M., Yan, X., Xu, H., Meininger, D. P., DeGraffenreid, M. R., He, X., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.065 · Cited by 46
Wamil, M., Andrew, R., Chapman, K. E., Street, J., Morton, N. M., & Seckl, J. R. (2008) · Endocrinology · doi:10.1210/en.2008-0420 · Cited by 46
Jamieson, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3570 · Cited by 40
Whorwood, C. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2296 · Cited by 38
Effect of Nutrient Ingestion on Total-Body and Splanchnic Cortisol Production in Humans
Basu, R., Singh, R., Basu, A., Johnson, C. M., & Rizza, R. A. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1335 · Cited by 37
Zhang, M., Lv, X., Li, J., Xu, Z., & Chen, L. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9993-0 · Cited by 30
Bryndová, J., Žbánková, Š., Kment, M., & Pácha, J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004659 · Cited by 27
Intravascular Glucocorticoid Metabolism during Inflammation and Injury in Mice
Dover, A. R., Hadoke, P. W. F., Macdonald, L. J., Miller, E., Newby, D. E., & Walker, B. R. (2007) · Endocrinology · doi:10.1210/en.2006-0996 · Cited by 22
Cofactor-specific modulation of 11β-hydroxysteroid dehydrogenase 1 inhibitor potency
Sahni-Arya, B., Flynn, M. J., Bergeron, L., Salyan, M. E. K., Pedicord, D. L., Golla, R., Ma, Z., Wang, H., Seethala, R., Wu, S. C., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.07.005 · Cited by 18
The syndrome of apparent mineralocorticoid excess
Cooper, M. S. (1998) · QJM · doi:10.1093/qjmed/91.7.453 · Cited by 15
Self-citationJang, C., Obeyesekere, V. R., Alford, F. P., & Inder, W. J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0619 · Cited by 13
Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice
D’Elia, M., Patenaude, J., & Bernier, J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90582.2008 · Cited by 13
Cited by
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
“This area has been recently reviewed Chapman et al., 2006a,b, 2009; Cooper and Stewart, 2009) and the iscussion here is restricted to recent developments and questions.”
Ramamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Management of type 2 diabetes: new and future developments in treatment
Tahrani, A. A., Bailey, C. J., Del Prato, S., & Barnett, A. H. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60207-9 · Cited by 533
Hocking, S., Samocha-Bonet, D., Milner, K.-L., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 276
“B); 4) sequestering a favorable factor (eg, 25-hydroxyvitamin D [25OHD]) or by conversion of a circulating factor to a form with more adverse metabolic activity (eg, conversion of cortisone to cortisol by 11 -hydroxysteroid dehydrogenase (10) (Sections VI.”
BackgroundThe metabolomic window into hepatobiliary disease
Beyoğlu, D., & Idle, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.030 · Cited by 215
“This is consistent with the upregulation of 11b-hydroxysteroid dehydrogenase type 1 (HSD11B1) in visceral obesity, metabolic syndrome, and type 2 diabetes [65,66] and its role in NAFLD [67].”
Background
Metadata
- Authors
- Cooper, M. S., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-12-01
- Volume
- 94
- Issue
- 12
- Pages
- 4645-4654
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2046188044
- Cited by
- 183
- References
- 103
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 7 · 2017: 12 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 20 · 2012: 24
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (acceptedVersion)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NF-SI-0508-10356)
- Versus Arthritis
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, hypothalamic-pituitary-adrenal axis, metabolic syndrome, inflammation, glucocorticoid metabolism, cortisone, hyperandrogenism, 11β-HSD1 inhibitors, immune response
- MeSH terms
- Adipose Tissue, Animals, Humans, Hypothalamo-Hypophyseal System, Inflammation, Pituitary-Adrenal System, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.